Literature DB >> 22102645

The At Home/Chez Soi trial protocol: a pragmatic, multi-site, randomised controlled trial of a Housing First intervention for homeless individuals with mental illness in five Canadian cities.

Paula N Goering1, David L Streiner, Carol Adair, Tim Aubry, Jayne Barker, Jino Distasio, Stephen W Hwang, Janina Komaroff, Eric Latimer, Julian Somers, Denise M Zabkiewicz.   

Abstract

Introduction Housing First is a complex housing and support intervention for homeless individuals with mental health problems. It has a sufficient knowledge base and interest to warrant a test of wide-scale implementation in various settings. This protocol describes the quantitative design of a Canadian five city, $110 million demonstration project and provides the rationale for key scientific decisions. Methods A pragmatic, mixed methods, multi-site field trial of the effectiveness of Housing First in Vancouver, Winnipeg, Toronto, Montreal and Moncton, is randomising approximately 2500 participants, stratified by high and moderate need levels, into intervention and treatment as usual groups. Quantitative outcome measures are being collected over a 2-year period and a qualitative process evaluation is being completed. Primary outcomes are housing stability, social functioning and, for the economic analyses, quality of life. Hierarchical linear modelling is the primary data analytic strategy. Ethics and dissemination Research ethics board approval has been obtained from 11 institutions and a safety and adverse events committee is in place. The results of the multi-site analyses of outcomes at 12 months and 2 years will be reported in a series of core scientific journal papers. Extensive knowledge exchange activities with non-academic audiences will occur throughout the duration of the project. Trial registration number This study has been registered with the International Standard Randomised Control Trial Number Register and assigned ISRCTN42520374.

Entities:  

Year:  2011        PMID: 22102645      PMCID: PMC3221290          DOI: 10.1136/bmjopen-2011-000323

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


Introduction

Background and rationale

The prevalence of mental health problems and addictions among homeless people is significantly higher than in the general population.1–3 Mental health problems among people who are homeless include severe and persistent mental illnesses such as schizophrenia, as well as more prevalent conditions such as mood and affective disorders.3 The co-occurrence of mental disorders and substance abuse is also common in this group, particularly among single men.1 2 While people with severe and persistent mental illness form a minority among the homeless population, with a pooled estimated prevalence for psychotic disorders of 12.7%,4 they are more likely to experience repeated episodes and longer periods of homelessness, as well as to require more health and social services than others experiencing homelessness.5 To date, a small number of controlled trials, all conducted in the USA,6 have examined the effectiveness of housing and support interventions for people with mental illness who are homeless. This research reveals that programs providing housing combined with supports to people with severe mental illness are effective in reducing homelessness and hospitalisations and in producing other positive outcomes (eg, well-being). Housing First involves providing homeless people with immediate access to subsidised housing, together with supports. No pre-conditions, such as bringing substance abuse under control or being stabilised on medications, are imposed. In the 1980s, Pathways to Housing in New York City introduced a consumer choice-oriented variant of Housing First, in which clients are offered their choice of subsidised scattered-site apartments (as opposed to one-size-fits-all congregate housing). Clients who have severe mental illness in addition to being homeless are also offered the support of a multidisciplinary team, following a well-defined program model called assertive community treatment (ACT). A number of studies have examined the effectiveness of Pathways to Housing in delivering housing and support services to people with severe mental illness including individuals with concurrent disorders.7–11 Based on these studies, Pathways to Housing has emerged as an empirically supported intervention for people with severe mental illness who are homeless, including those with concurrent disorders. It has now been implemented in Calgary and Edmonton, Alberta and in several US cities.12 Because of differences in healthcare and social policies between the USA and Canada, it is not known if the Pathways to Housing approach will prove to be effective in the Canadian context, or more broadly in other international contexts. Moreover, it is not known if the approach will be equally effective among different sub-populations (eg, defined by gender, age, presence of concurrent disorders, Aboriginal status and immigration status) located in different cities across Canada. Further, while previous research examining Pathways to Housing focused on outcomes such as housing stability, housing problems, psychiatric symptoms, substance use, service utilisation and perceived housing choice, none of the studies examined other important outcomes of interest, such as community integration, social functioning, employment, recovery or physical health. As well, the cost-benefit or cost-effectiveness of the program compared to standard care was not evaluated. Finally, the Pathways to Housing studies did not incorporate a fidelity assessment to determine if the key elements of the approach were implemented nor did they examine how fidelity related to outcomes. Developed independently in Toronto, Streets to Homes is a Canadian variant of Housing First,13 which Toronto City Council initiated in 2005 as a strategy for ending street homelessness. The Canadian and US programs share many of the same elements such as services to assist people to find and move into housing of their choice followed by supports, so they can be successfully and stably housed. However, the Streets to Homes program uses intensive case management (ICM) rather than ACT as the service delivery model and serves a broader population than Pathways to Housing, as it includes all those who are on the streets rather than targeting only those with severe mental illness. While no published study evaluates Streets to Homes directly, two US studies suggest that this approach may be effective in providing care to a lower need subgroup that has otherwise not been included in much of the published literature.14 15 Both studies examined interventions targeting veterans of the armed forces in the USA. Using an experimental design, Rosenheck et al15 compared the effectiveness of housing and support in the form of comprehensive case management to standard care. The study found that the combined housing and support approach was superior to standard care in achieving housing stability and reducing hospitalisations and prison stays. In the other study, O'Connell et al14 used a quasi-experimental design to evaluate the effectiveness of regular housing and case management compared to the traditional approach of multistage continuum housing. Both groups showed significant improvements in housing outcomes, clinical status, community functioning and quality of life. Multistage housing participants, who had more difficulties in these areas at baseline, experienced greater improvement to the point that they were not significantly different from participants accessing regular housing and case management after 24 months. Residents in multistage housing, however, had significantly greater healthcare costs, due to greater use of inpatient care. Given the promising evidence of the Housing First model and interest in the less expensive ICM support approach, the present study was designed to stratify individuals by need level and evaluate these two service delivery variants. The research design is a pragmatic, multi-site field trial of the effectiveness of Housing First with concomitant economic and qualitative process evaluations. It is intended to provide policy-relevant evidence about whether a complex housing and support intervention works under real life conditions in five Canadian cities. This demonstration project includes funding for the implementation of the intervention through contracts with existing service agencies and rent supplements for participants. In order to ensure local buy-in and to develop innovative Housing First services that are tailored to local circumstances, each city had the option of defining a third intervention arm that was specific to their site (described below). This paper describes the study protocol including core quantitative research questions and methods that are common to all sites. It also includes an adaptation of the standard CONSORT description of pragmatic16 trials of non-pharmacological17 and complex interventions.18 Planning for the study began in the spring of 2008, first participants were recruited in the autumn of 2009, and data collection is to be completed in the spring of 2013.

Objectives

The At Home/Chez Soi study seeks to involve a range of stakeholders in a collaborative research and knowledge translation process that addresses the following objectives: To determine whether Housing First results in better outcomes than treatment as usual (TAU) for unaccompanied homeless adults with high and moderate needs living in five urban settings with respect to: (a) housing stability; (b) quality of life; (c) medical, psychological and physical health status; (d) social functioning; and (e) community integration. To examine the cost-effectiveness of Housing First in comparison to TAU. To examine the correlates of different trajectories of interest such as housing stability, mental health, medical conditions and employment over time. To identify the critical ingredients of the Housing First model and what modifications are needed to effectively serve particular sub-populations (eg, Aboriginals, ethnic groups, those living in congregate or rural settings).

Methods and analysis

Design

The study's basic design is a randomised controlled trial (RCT) that is being conducted in five cities in Canada: Vancouver, British Columbia; Winnipeg, Manitoba; Toronto, Ontario; Montreal, Quebec; and Moncton, New Brunswick. Prior to randomisation, participants at all sites except Moncton are stratified according to the severity of their psychiatric problems into High Need or Moderate Need groups. Those in the High Need group are randomised into Housing First and ACT (HF+ACT) or TAU, while those with Moderate Need are randomised to Housing First and ICM (HF+ICM) or TAU. In Moncton, there are not enough people who are homeless to allow for a stratified design, so all participants are randomised to HF+ACT or TAU, although the team responds flexibly to individual needs. All sites have been given the option of an additional third arm. A typical design for one site is presented in figure 1.
Figure 1

Vancouver study design. CONG, congregate housing and supportive services (site-specific arm); HF+ACT, Housing First and assertive community treatment; HF+ICM, Housing First and intensive case management; TAU, Treatment as usual.

Vancouver study design. CONG, congregate housing and supportive services (site-specific arm); HF+ACT, Housing First and assertive community treatment; HF+ICM, Housing First and intensive case management; TAU, Treatment as usual. In Vancouver (as indicated in figure 1), and also in Winnipeg, Toronto and Montreal, participants are being randomised to a third site-specific intervention arm, in addition to HF+ACT and HF+ICM. In Vancouver, this intervention consists of congregate housing (a former hotel in which all of the residents are formerly homeless people with a mental illness) or project-based housing, which is a variation on Housing First that has been found effective with homeless substance using clients.19 In Winnipeg, the intervention is an Aboriginal peer support model for the moderate need group. In Toronto, an ICM intervention specifically for ethno-racial minorities is being tested for moderate need participants. In Montreal, moderate need participants are being randomised to an institutional versus a non-profit community-based ICM provider; both groups of participants are also invited to participate in a trial of supported employment. Moncton does not have a third arm, but there is a small, pilot project of Housing First in a rural setting. Details of the site-specific interventions are described in appendix 1.

Recruitment and data collection

Strategies to ensure adequate participation include seeking referrals from a wide variety of community agencies that serve the homeless, including shelters, drop-in centres, outreach teams, mental health teams, inpatient programs and criminal justice programs. Brochures describing the study and the eligibility criteria have been distributed and local service providers have provided advice about recruitment settings and procedures. Participants will be followed for 2 years after enrolment. Face-to-face follow-up interviews are being conducted at 6, 12, 18 and 24 months, and telephone interviews at 3, 9, 15 and 21 months. Due to the inclusion of questionnaires on service use and housing trajectories (unavoidable given study objectives), blinding of interviewers was infeasible. The schedule of instruments administered at each interview session is presented in table 1. A more detailed description of the instruments can be found in appendix 2. The number and timing of the interview sessions were dictated by two considerations: a desire to track the longer term trajectory of change for each individual; and recognition of the fact that it is likely that, due to the nature of their problems, some participants, especially in the TAU groups, may miss appointments. The statistical techniques that will be used (described below) can deal with missing data, as long as there are at least three data collection points for a given outcome measure, so that the frequency of the interviews maximises the number of people whose data can be analysed.
Table 1

Key outcome and process domains and administration schedule

DomainVariablesInstruments
Housing

Stability

Perceived quality

Observer-rated quality

Residential Time-Line Follow-Back Inventory20 *

Perceived Housing Quality Scale21 22

Purpose developed observer-rated Housing Quality Scale

Health status

Mental

Physical

Modified Colorado Symptom Index (CSI)23

Global Assessment of Individual Needs GAIN Substance Problem Scale24 25

EQ-5D Visual Analog Scale26–28

Functioning including community integration, recovery and vocational attainment

Independent living

Response to stress

Money management

Social

Meaningful activity, etc

Multnomah Community Ability Scale (MCAS)29–31

Adapted community integrations scales (physical and psychological integration)32–34

Recovery Assessment Scale35–37

Vocational Time-Line Follow-Back38 *

Quality of life

Generic quality of life and

health-related quality of life

EQ-5D36–38

SF-1228 39 40

SF-6D41

Qoli-2042

Healthcare, social services and justice system use and costsFor example, emergency room visits, hospital admissions, primary and specialist care visits, social agency visits, etc. Charges, court appearances, nights in jail or remand, etcComposite checklists of service use and justice system-related events, to be combined with administrative data from several mostly site-specific provincial government sources to which costs will be attached using standard costing methods

Indicates instruments administered every 3 months; all others are every 6 months, except the Housing Quality Scale which is only at 21 months.

Key outcome and process domains and administration schedule Stability Perceived quality Observer-rated quality Residential Time-Line Follow-Back Inventory20 * Perceived Housing Quality Scale21 22 Purpose developed observer-rated Housing Quality Scale Mental Physical Modified Colorado Symptom Index (CSI)23 Global Assessment of Individual Needs GAIN Substance Problem Scale24 25 EQ-5D Visual Analog Scale26–28 Independent living Response to stress Money management Social Meaningful activity, etc Multnomah Community Ability Scale (MCAS)29–31 Adapted community integrations scales (physical and psychological integration)32–34 Recovery Assessment Scale35–37 Vocational Time-Line Follow-Back38 * Generic quality of life and health-related quality of life EQ-5D36–38 SF-1228 39 40 SF-6D41 Qoli-2042 Indicates instruments administered every 3 months; all others are every 6 months, except the Housing Quality Scale which is only at 21 months. Most of the primary data are collected via participant interviews using laptop computer-assisted interviewing and entered to a highly secured central database via wireless technology. Several strategies are being used to optimise data quality. First, instruments not previously used in this population were pre-tested in three sites using cognitive interviewing techniques (these findings are reported in a separate, forthcoming publication). Second, interviewers receive ongoing face-to-face and webinar-based training. Third, type and range of data values and mandatory entry are built in to entry fields in the database. Fourth, questions from interviewers are fielded centrally and decision rules made where necessary and circulated to all sites, followed by in-depth review at annual site visits. Fifth, data managers at each site use common data checking routines and findings shared with a multi-site data quality committee. Sixth, the authority to change data elements is restricted to a limited number of personnel and all data changes are logged electronically.

Plans to promote continued participation

Previous longitudinal studies of homeless individuals have retained 60%–85% of participants over follow-up periods of 18–36 months. Our goal is to retain 80% of participants over 2 years of follow-up, using methods that have been proven to be effective in tracking and retaining homeless and marginalised study participants.43–48 Specifically, efforts have been made to establish trust and rapport with participants at first contact and to explain the importance of their participation in follow-up interviews. At the time of enrolment, participants are asked to provide contact information not only for themselves but also for friends, relatives, service providers and case workers who are most likely to know the participant's future whereabouts and who may be contacted in order to locate them. Participants are also asked to give consent for the social services department that administers benefit payments to disclose their updated contact information to the research team. To facilitate tracking, participants are given a phone number to call-in for a very brief update every month that no interview is scheduled. Every 3 months, in addition to updating contact information, a short interview of 10 min is conducted asking participants about their housing and work situations since the last interview. Participants receive financial compensation for all these updates as well as for interviews. Some sites have also obtained ethics approval to offer more significant compensation for interviews of control group participants after the baseline interview, on the grounds that the opportunity cost of time is higher for TAU than for experimental group participants, who can store food provisions in their own apartment. Participants also have the option to contact a research staff member by phone at these time points to provide updated contact details and other information. They receive the same honorarium as those contacted in-person. Participants are also encouraged to contact a research staff member whenever they move. Finally, with the consent of participants, hospitals, homeless shelters, prisons and treatment centres can be contacted in an effort to locate those who have been lost to follow-up.

Sample size

Although the aim is to combine participants across sites within each condition, it is recognised that (a) there will most likely be baseline differences across sites, reflecting the different demographic composition of each city; and (b) each site will want to analyse data from their site-specific arm. Consequently, the study is powered so that each site would be able to detect an effect size of 0.5 between TAU and the treatment arms for the major outcome variables. With an α of 0.05 and β of 0.20, sufficient power for analysis will require 63 participants per treatment arm. Given the challenges in following a homeless population over a 2-year follow-up period, an attrition rate of 40% was estimated and recruitment targeted at 100 participants per arm. The exception to this recruitment target is the small pilot study in a rural region adjacent to Moncton, which draws on a matched control design with 25 individuals in each group. The combined sample size of approximately 2500 (which includes additional participants in some of the site-specific arms) will also allow for the use of hierarchical linear modelling (described below) as the primary data analytical strategy.

Participants

Criteria for inclusion are: Legal adult status (aged 18 or older/19 in British Columbia) Housing status as absolutely homelessness OR precariously housed, according to definitions in appendix 3 The presence of a mental disorder with or without a co-existing substance use disorder, determined by DSM-IV criteria on the Mini International Neuropsychiatric Interview (MINI44) at the time of entry (details in appendix 3). Exclusion criteria are: Currently a client of another ACT or ICM program No legal status as a Canadian citizen, landed immigrant, refugee or refugee claimant Those who are relatively homeless (as defined in appendix 3).

Randomisation

During the initial eligibility and baseline interviews, participants are administered the Mini International Neuropsychiatric Interview49 and the Multnomah Community Ability Scale,29 50 and are asked questions about service and housing history. If a participant meets eligibility criteria, informed written consent is obtained by the interviewer and he or she is enrolled in the study. Based on an algorithm (see appendix 4) that includes information about diagnosis, social functioning and service use, the participant is assigned to the high need or moderate need condition (this allocation can be modified if relevant information becomes known within a month that changes the level of need, as determined by a central review panel). Randomisation is performed via computer by the central data gathering centre, using adaptive randomisation procedures.51 The decision is immediately sent to the interviewer's laptop at the completion of the session. This approach to randomisation continually changes the probability of being assigned to each group, depending on the number of participants in each. Because each arm of the trial has a maximum of 100 participants, adaptive randomisation better ensures balance between the groups than strict randomisation. Block randomisation was considered infeasible, as it is desirable for participants to know their group assignment immediately after the interview; if block randomisation were used, they would have to wait until enough people were enrolled to complete the block, which could take a few weeks.

Interventions

Housing First as defined in the Pathways to Housing and Street to Homes approaches creates a recovery-oriented culture that puts participant/tenant choice at the centre of all its considerations with respect to the provision of housing and support services. It operates on the principle that all homeless individuals with mental illness should be offered the opportunity to live in permanent housing of varying types that is otherwise available to people without psychiatric or other disabilities. Assertive in-reach and outreach identifies and engages potential participants avoiding any coercive tactics. Rent supplements are provided so that participants pay 30% or less of their income for housing if in the private market.i Participants may also live in social, supported or alternative housing in which case the rent supplement is not required. Participants must also be provided access to furniture. Treatment and support services are offered by clinicians/providers who are based off-site. Legal rights to tenancy are in place. Whenever possible, leases are in the name of the participant, not the program, to empower participants/tenants in their recovery and autonomy, and assist them in achieving full independence. In essence, it is a housing program with supports delivered without any conditions of housing readiness such as engagement in treatment. However, participants must agree to have 30% of their income paid directly as rent and to be visited in their unit a minimum of once a week by program staff for a length of time that is appropriate to their level of need. (In practice however, participants are not required to agree to automatic withdrawal of their rent contribution from their cheques, and there is some flexibility in the frequency of visits.) The program has control over participant access to housing stock, primarily by facilitating access to rental apartments from community landlords. For housing in the private market (scattered-site), a maximum of 20% of the total units in any one building is dedicated to the program to facilitate community integration. The service array provides support and treatment for mental illness and, where necessary, substance abuse, and differs depending upon the level of individual severity and disability. All services are individualised based upon participant need and preference, including cultural adaptations. Services are provided in the home or community. Service teams work with participants to obtain and maintain housing, promote mental and physical health and reduce the negative impacts of substance use. For those individuals with high needs who have not been able to access traditional housing and services, these services are provided using a modified ACT team as exemplified by Pathways to Housing and described in more detail elsewhere.52 For individuals with moderate needs, services are provided using ICM as exemplified by the Streets to Homes program.ii In this model, consumers are linked primarily to one worker rather than a whole team. Discontinuation of the intervention will occur only in exceptional circumstances when an external review panel determines that there are unmanageable safety risks. Table 2 outlines the key features of the Housing First experimental intervention model and the unique elements of the two service delivery modalities.
Table 2

Key features of the experimental intervention

Housing First model

Recovery oriented culture

Based on consumer choice for all services

Only requirements: income paid directly as rent; visited at a minimum once a week for pre-determined periods of follow-up supports

Rent supplements in private market: participants pay 30% or less of their income or the shelter portion of welfare

Treatment and support services voluntary—clinicians/providers based off site

Legal rights to tenancy (no head leases with agency rather than individual)

No conditions on housing readiness

Program facilitates access to housing stock

Apartments are independent living settings primarily in scattered sites

Services individualised, including cultural adaptations

Reduce the negative consequences of substance use

Availability of furniture and possibly maintenance services

Tenancy not tied to engagement in treatment

ACT, assertive community treatment; ICM, intensive case management.

Key features of the experimental intervention Recovery oriented culture Based on consumer choice for all services Only requirements: income paid directly as rent; visited at a minimum once a week for pre-determined periods of follow-up supports Rent supplements in private market: participants pay 30% or less of their income or the shelter portion of welfare Treatment and support services voluntary—clinicians/providers based off site Legal rights to tenancy (no head leases with agency rather than individual) No conditions on housing readiness Program facilitates access to housing stock Apartments are independent living settings primarily in scattered sites Services individualised, including cultural adaptations Reduce the negative consequences of substance use Availability of furniture and possibly maintenance services Tenancy not tied to engagement in treatment Recovery-oriented ACT team Participant/staff ratio of 10:1 or less and includes a psychiatrist and a nurse Program staff are closely involved in hospital admissions and discharges Teams meet daily and include at least one peer specialist as staff Seven day a week, 24 h crisis coverage Intensive case management for a minimum of 1 year once housed Participant/staff ratio of 20:1 or less Integrated efforts across multiple workers and agencies Workers accompany participants to appointments Centralised assignment and monthly case conferences Seven day a week, 12 h per day coverage ACT, assertive community treatment; ICM, intensive case management. The elements described above define the program model upon with the measurement of fidelity is based, using a new Housing First scale52 developed during the formative evaluation phase of this study. It is based upon the Housing First logic model and draws upon previous fidelity measures of recovery-oriented ACT and supportive housing. It will be completed following annual site visits by a team of external assessors who observe team meetings, review documentation and charts, and interview staff and participants. It is recognised that there may be justifiable deviations from complete fidelity due to tailoring to local conditions. The third arm, site-specific, interventions have unique, but complementary attributes which will be described more fully in reports of the comparisons within each city. The interventions are delivered by 12 existing service agencies who were the successful applicants from each of the five pre-selected cities to a request for proposals that was issued by the Mental Health Commission of Canada. The agencies had to demonstrate their ability to hire, train and supervise staff for the housing and support teams and be financially accountable in the 6-month start-up period. Technical assistance and training on the Housing First intervention is provided on an ongoing basis by a centralised team of experts. Fidelity visits and qualitative interviews are conducted as a part of an extensive process evaluation (Macnaughton E, Goering P, Nelson G. Using Mixed Methods within the At Home/Chez Soi Housing First project: A strategy to evaluate the implementation of a complex population health intervention for people with lived experience of homelessness and mental illness. Submitted, Can J Public Health).

Usual care

In each city, the housing intervention(s) will be compared to TAU. The intent is to compare a complex new service delivery approach to the ‘real life’ experience that exists in current systems of care. This means that there will be no active intervention introduced by the study for the TAU group. ‘Usual care’ does not mean ‘no care’; it is what people would normally get if this project did not exist. It is recognised that some individuals in the TAU group may over time, through new or existing programs, access some of the same components that make up the housing intervention. It is also likely that the usual care service patterns will differ across cities. This unpredictable mix of service packages is a phenomenon of interest. It is measured through the common protocol and included in the analysis of process and outcomes.

Outcomes

The key outcome domains for measuring the effectiveness and cost-effectiveness of the intervention are those that have consistently been found to be relevant in studies of housing interventions for individuals with mental health issues. These are listed in table 1. As is acknowledged in the guidelines for evaluations of complex interventions,18 more than one outcome is needed to reflect the multiple effects that are expected. The primary outcomes for assessment of effectiveness are housing stability (as defined by a joint function of number of days housed and number of moves53) and social functioning; secondary outcomes include mental and physical health status, community integration and quality of life. For the economic analyses, system use and costs will be used to calculate the costs of improvements in the primary outcomes of quality of life and days housed. Note that our focus here is on outcomes that will be informed by cross-site or multi-site data. A complementary set of outcomes will be examined through site-specific analyses, with similar analytical methods.

Statistical analyses

Within each of the high and moderate need groups, participant data will be clustered within site and over time. Missing data are expected due to missed appointments, drop-outs and death. One technique to deal with missing data when the outcome is continuous, is hierarchical linear modelling (HLM; also called random effects regression, latent growth curve analysis and many other names).54 In brief, a regression line is fitted to each person's data, resulting in two parameters: a slope and an intercept, and the analysis focuses on variables that affect these. A minimum of three data points are necessary to fit a straight line, in order to give an estimate of the error of the fit. If there are more than three data points, more complex lines can be fitted (eg, quadratic, cubic), which may better approximate the actual trajectories of change. We do not anticipate differences in the intercept within each site, as randomisation is expected to balance out baseline differences between the groups. However, there may be differences in the intercepts between sites, reflecting differences within the client populations served in each city. We anticipate that the primary factor affecting the slope (ie, the rate of change of the outcome measure) will be group membership (ie, housing intervention or TAU). If there is any significant unexplained variance after baseline differences and group membership have been accounted for, we can look for other factors influencing the slope, such as gender, age, amount of time spent homeless, diagnosis and so forth. Another analytic option that will be considered is generalised estimating equations (GEE),55 which can also accommodate clustered, serially correlated data with missing values. The choice of techniques will be based on the nature of the data and the research question. The analysis plan will combine the TAU groups within need level and across sites. However, it may turn out that the demographic characteristics of participants and available treatments differ so widely from city to city that this will not be possible. In that case, it will be necessary to compare each treatment group to its site-specific TAU group. There will be an interim analysis using 1-year follow-up data, with the final analyses based on the 2-year data. In order to preserve an α level of 0.05, the 1-year analyses will use a nominal critical value of 0.01, and the 2-year analyses will use 0.04. There are no universally accepted methods for dealing with missing data; the only consensus is that sensitivity analyses should be conducted using different methods and comparing the results. In this study, data can be missing at four levels: individual items within instruments, the instruments themselves, specific appointment or data points, and people (due to loss to follow-up or death). We do not expect many individual items to be missing, as most of the instruments will be computer-administered. However, people may refuse to answer a specific question. In such cases, we will either follow the recommendations for prorating (if any) of the scale developer or use multiple imputation. If an instrument or appointment is missed, we will attempt to gather the information at a later visit. Irregular timing of instruments administered multiple times is not a problem for HLM, as it can account for this in deriving the slope for each person. Drop-outs and deaths, though, are a different matter. We cannot assume that these data are missing at random or missing completely at random,56 which is an assumption of most imputation methods. If there are at least three data points for these people, we will analyse them separately to determine if their slopes differ significantly from those of people who remained in the study. If they do not, we will be somewhat more comfortable including them in the analyses; otherwise, they will need to be analysed separately. As previously noted, though, we will analyse the missing data in a number of ways, including HLM, multiple imputation and last observation carried forward. The cost-effectiveness analysis will be conducted using net benefit regression.57 The regression framework allows the implementation of the statistical plans described above. Furthermore, the net benefit regression framework features parametric and non-parametric options to characterise uncertainty in the cost-effectiveness analysis data.58 In addition to incremental net benefit by willingness to pay curves, we will also present our results using cost-effectiveness acceptability curves (CEACs) and scatterplots on the cost-effectiveness plane. Net benefit regression has been used to analyse the cost-effectiveness of various programs for study participants such as those in our study.59

Data access

Quantitative data are entered directly into laptops configured specifically for the project and maintained by Health Diary, a contracted service provider who will manage data storage for the study in an off-site centralised server with high levels of physical and network security. No data are stored on the hard drive and after entry hard copies are kept in secure storage at each site. Access to the data is limited to authorised users only, using a multi-level permissions protocol that specifies roles and types of data access using a need-to-know principle. Contractual documents state that the central dataset is the property of and under the control of the Mental Health Commission of Canada to ensure access for all members of the national and local research teams. After the project is complete, investigators will be able to access all or any part of the dataset for additional analyses, contingent upon appropriate Research Ethics Board (REB) approvals.

Ethics and dissemination

This study has been registered with the International Standard Randomised Control Trial Number Register and assigned ISRCTN42520374. REB approvals have been received from universities or healthcare institutions in each of the five sites (a total of 10 institutions, mostly universities). Additionally, we have REB approval from the university-affiliated teaching hospital in which the coordinating centre is based to conduct secondary analyses and move the data across provincial lines and store them in a central, secure location. A study of this nature raises ethical issues not faced by more traditional interventions involving, for instance, medications or psychotherapy. These include the possibility of harm to the participants, research staff and clinical personnel, due to the nature of the participants' psychiatric problems and their living situations. Analogous to the Data Safety Monitoring Boards which are established in trials of medications, the At Home/Chez Soi Project has set up a Safety and Adverse Events Committee, composed of representatives from the national research group, participants, clinical staff and an ethicist.60 It is charged with receiving and reviewing reports regarding any serious events associated with the project. The results of the multi-site analyses of outcomes at 12 months and 2 years will be reported in a series of core scientific journal papers. Extensive knowledge exchange activities with non-academic audiences will occur throughout the duration of the project.
Instrument and relevant published referencesPsychometric information

Mini International Neuropsychiatric Interview 6.0 (MINI 6.0)

Sheehan DV, Lecrubier Y, Harnett-Sheehan K, et al. Reliability and validity of the MINI International Neuropsychiatric Interview (MINI) according to the SCID-P. Eur Psychiat 1997;12:232–41.

Lecrubier Y, Sheehan D, Weiller E, et al. The MINI International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997;12:224–31.

Sheehan DV, Lecrubier Y, Harnett-Sheehan K, et al. The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 1998;59(Suppl 20):22–33.

Amorim P, Lecrubier Y, Weiller E, et al. DSM-IH-R psychotic disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry 1998;13:26–34.

Description (with information from www.medical-outcomes.com):

The MINI is a short, structured diagnostic interview that was developed in 1990 by psychiatrists and clinicians in the United States and Europe for DSM-IV and ICD-10 psychiatric disorders. With an administration time of approximately 15 minutes, the MINI is often used for psychiatric evaluation and outcome tracking in clinical psychopharmacology trials and epidemiological studies. In this study, we will be using the modules for diagnosis of major depressive episodes, suicidality, manic and hypomanic episodes, post-traumatic stress disorder, alcohol dependence/abuse, substance dependence/abuse, psychotic disorders and generalised anxiety disorders.

MINI website https://www.medical-outcomes.com/index.php:

“The M.I.N.I. has been validated against the much longer Structure Clinical Interview for DSM diagnoses (SCID-P) in English and French and against the Composite International Diagnostic Interview for ICD-10 (CIDI) in English, French and Arabic. It has also been validated against expert opinion in a large sample in four European countries (France, United Kingdom, Italy and Spain). According to researchers at the National Institute of Mental Health's (NIMH) Division of Clinical and Treatment Research, the M.I.N.I. is a fully validated and more time-efficient alternative to the SCID-P and CIDI.” (Sheehan et al, 1998)

Validity

Concordance of MINI-CR with SCID-P

MINI diagnoses characterised by good or very good κ values with only one value (for current drug dependence) below 0.5

Sensitivity 0.70 or greater for all but three diagnoses (dysthymia, obsessive compulsive disorder (OCD) and current drug dependence)

Specificities and negative predictive values (NPVs) 0.85 or higher across all diagnoses

Positive predictive values (PPVs) 0.75 or higher for major depression, lifetime mania, panic disorder, lifetime agoraphobia, lifetime psychotic disorder, anorexia and post-traumatic stress disorder

PPVs 0.60–0.74 for current mania, generalised anxiety disorder (GAD), current agoraphobia, OCD, current alcohol dependence, lifetime drug dependence and bulimia

PPVs 0.45–0.59 for dysthymia, current psychotic disorder, lifetime social phobia and current drug dependence

Concordance of MINI-CR with CIDI

κ Values good or very good for all diagnoses (only simple phobia and GAD below 0.50)

Sensitivity 0.70 or greater for all but four diagnoses (panic, agoraphobia, simple phobia, lifetime bulimia)

Specificity 0.70 or greater for all

NPVs very good (0.88 or higher)

PPVs 0.75 or higher for major depression, alcohol and drug dependence, and panic disorder

PPVs 0.60–0.74 for lifetime manic episode, agoraphobia and simple phobia

PPVs 0.45–0.59 for current manic episode, social phobia and lifetime bulimia

PPV poor (0.34) for GAD

For psychotic disorders, concordance was very good

Reliability

Kappas listed by 23 diagnoses

Inter-rater kappas all above 0.75 and 70% 0.90 and higher

Test-retest kappas 61% of values above 0.75 (one, for current mania, below 0.45)

Test-retest was carried out using a second interviewer for the retest.

Modified Colorado Symptom Index (CSI)

Shern DL, Wilson NZ, Saranga Coen A, et al. Client outcomes II: longitudinal client data from the Colorado Treatment Outcome Study. Milbank Q 1994;72:123–48.

Boothroyd RA, Chen HJ. The psychometric properties of the Colorado Symptom Index. Adm Policy Mental Health 2008;35:370–8.

Conrad KJ, Yagelka JR, Matters MD, et al. Reliability and validity of a modified Colorado Symptom Index in a national homeless sample. Ment Health Serv Res 2001;3:141–53.

Greenwood RM, Schaefer-McDaniel NJ, Winkel G, et al. Decreasing psychiatric symptoms by increasing choice in services for adults with histories of homelessness. Am J Commun Psychol 2005;36:223–8.

Description (with information from Greenwood et al, 2005 and Conrad et al, 2001): This 14-item instrument assesses the presence and frequency of psychiatric symptoms participants experienced within the past month (eg, ‘How often have you felt tense, nervous, worried or afraid?’). Responses are coded on a 5-point Likert scale with answer choices ranging from 0 (not at all) to 4 (at least every day). A higher score indicates a higher level of psychiatric symptomatology.

Reliability

In Boothroyd (2008), with a sample of 3874 adult Florida Medicaid respondents, test-retest reliability r=0.71, internal consistency α=0.92

In Conrad et al (2001), with a sample of 1381 homeless adults getting treatment for substance abuse or mental health issues in eight study sites, test-retest r=0.79, internal consistency across study sites high (α=0.90)

Cut-points (Boothroyd, 2008)

Using 30 as a clinical cut-off score denoting the need for further psychiatric assessment, sensitivity was 0.76 and specificity was 0.68.

Using 30 as a cut-off PPV (proportion of individuals with positive assessment who actually have the illness) was 0.32 and NPV (proportion of individuals with a negative assessment who do not have the illness) was 0.93.

A receiver operating characteristic (ROC) curve analysis shows that the CSI is a ‘fair to good’ discriminator of individuals with psychiatric disabilities.

Validity

Boothroyd (2008) reported that correlation between respondents' CSI scores and the reported need for assistance (ie, functioning) was 0.50, suggesting good convergent validity with SF-12.

Conrad et al (2001) reported positive correlations with the Brief Symptom Index providing evidence of content validity.

Global Assessment of Individual Need—Substance Problem Scale (GAIN SPS)

Dennis ML, Chan Y, Funk RR. Development and validation of the GAIN Short Screener for Internalising, Externalising and Substance Use Disorders and Crime/Violence Problems among adolescents and adults. Am J Addict 2006;15:80–91.

Dennis ML, White MK, Titus JC, et al. Global Appraisal of Individual Needs (GAIN): Administration Guide for the GAIN and Related Measures (Version 5). Bloomington, IL: Chestnut Health Systems, 2006.

Description (information from GAIN website):

The GAIN Substance Problem Scale is a 16-item subscale of the larger Global Appraisal of Individual Needs (GAIN) which is a standardised biopsychosocial instrument that integrates research and clinical assessment for people presenting for substance abuse treatment. The GAIN SPS is composed of 16 recency items (eg ‘When was the last time you…?’): 7 based on DSM-IV criteria for dependence, 4 for abuse, 2 for substance-induced health and psychological problems, and 3 on lower severity symptoms of use (hiding use, people complaining about use, weekly use). Higher scores represent greater severity of drug problems. The scale includes physiological, psychosocial and social criteria, as well as an item on comorbid use with drugs that is likely to exacerbate the other problems.

All info from GAIN Overview from http://www.chestnut.org/LI/GAIN/index.html

Reliability/validity

Internal consistency for Substance Problem Scale (Lifetime) is 0.90.

For GAIN-I (full instrument), studies with adults and adolescents have found good reliability in test-retest situations on days of use and symptom counts (r=0.7–0.8), as well as diagnosis (κ=0.5–0.7). Self-reports were consistent (κ=0.5–0.8 range) with parent reports, on-site urine and saliva testing, and laboratory-based EMIT and GC/MS urine testing.

Self-reports on the GAIN were found to be consistent with a multi-method estimate based on any self-report or positive urine or saliva test for any drug (κ=0.56), cocaine (κ=0.52), opioids (κ=0.55) and marijuana (κ=0.75), with no one method being superior across all drugs.

Using discriminant analysis, the GAIN scales could also reliably predict independent and blind staff psychiatric diagnoses of co-occurring psychiatric disorders including ADHD (κ=1.00), Mood Disorders (κ=0.85), Conduct Disorder/Oppositional Defiant Disorder (κ=0.82), Adjustment Disorder (κ=0.69), or the lack of a non-substance use diagnosis (κ=0.91) and to discriminate the primary other disorders across these conditions (κ=0.65).

Cut-points

0 mild/1–9 moderate /10–16 severe

Multnomah Community Ability Scale (MCAS)

Barker S, Barron N, McFarland BH, et al. A community ability scale for chronically mentally ill consumers. Commun Ment Health J 1994;30:459–72.

Dickerson FB, Origoni AE, Pater A, et al. An expanded version of the Multnomah Community Ability Scale: anchors and interview probes for the assessment of adults with serious mental illness. Commun Ment Health J 2003;39:131–7.

Description (modified from MCAS website—www.multnomahscale.com):

This 17-item scale was first created in 1983 by community mental health case managers. It measures degree of functional ability through 17 indicators. The indicators are rated on a 5-point scale and are grouped into four sections:

Health: Physical, mental and emotional symptoms that interfere with daily functioning (5 indicators)

Adaptation: Critical abilities for coping with serious mental illness and surviving in the community (3 indicators)

Social skills: How people with psychiatric disabilities interact with others (5 indicators)

Behaviour: Personal actions that affect community tenure and positive service outcomes (4 indicators).

Anchors and interview probes were developed by Dickerson et al (2003).

Dickerson et al (2003)

Inter-rater reliability for MCAS with interview probes

The infraclass correlation coefficient (ICC) was 0.96 for the Total Score, 0.91 for the Interference with Functioning subscale, 0.99 for the Adjustment to Living subscale, 0.87 for the Social Competence subscale, and 0.96 for the Behavioural Problems subscale.

Barker et al (1994)

Inter-rater reliability for the original scale

ICC was 0.85 for Total Score, 0.70 for the Interference with Functioning subscale, 0.75 for the Adjustment to Living subscale, 0.75 for the Social Competence subscale, and 0.78 for the Behavioural Problems subscale.

Test-retest reliability for the original scale

ICC was 0.83 for Total Score, 0.77 for the Interference with Functioning subscale, 0.82 for the Adjustment to Living subscale, 0.71 for the Social Competence subscale, and 0.70 for the Behavioural Problems subscale.

Cronbach's α was 0.90, suggesting good internal consistency.

Validity

17 MCAS items were compared with ‘criterion’ variables related to state mental hospital use and were found to correlate highly with these variables.

Found that the instrument is predictive of subsequent state and local hospital admissions (instrument has substantial p<0.001 prospective predictive validity—χ2 test for trend >6.05 with one degree of freedom, p=0.1)

Cut-points (excerpt from Toronto site proposal)

“Barker et al (1994) proposed criterion scores for interpreting levels of disability in individuals with severe mental illness: total MCAS scores of 17 to 47 indicating severe disability, 48 to 62 moderate disability and 63 to 85 indicating little disability. Other investigators similarly report MCAS ratings in the 40s for inpatients (19), in the 50s for ambulatory patients receiving a high level of community support (20) and in the 60s for clients in lower intensity outpatient care (19). In the Community Mental Health Evaluation Initiative (CMHEI), mean MCAS scores at intake to ACT and ICM were 50.7 (6.6) and 50.9 (8.0), respectively, with approximately 99% of ACT participants and 91% of ICM participants having MCAS scores below 62.” (Carolyn Dewa, personal communication)

EQ-5D

The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208.

Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53–72.

Lamers LM, Bouwmans CAM, van Straten A, et al. Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ 2006;15:1229–36.

Description (with information from EQ-5D user guide):

EQ-5D is a self-administered standardised measure of health status developed by the EuroQoL Group in order to provide a simple, generic measure of health for clinical and economic appraisal. It provides a simple descriptive profile and single index value for health status. The EQ-5D descriptive system has five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has three levels: no problems, some problems and severe problems. The visual analogue scale records the respondent's self-rated health on a vertical, visual analogue scale where endpoints are labelled ‘best imaginable health state’ and ‘worst imaginable health state’. This information can be used as a quantitative measure of health outcome as judged by the individual respondents.

Extensive general psychometric information is available at http://www.euroqol.org/

The information most relevant to our study is from Lamers et al (2006)

Utilities

This was a Dutch multi-site randomised trial of 616 patients with mood and/or anxiety disorders.

EQ-5D and SF-6D utilities differed significantly between patients of adjacent severity groups.

Mean utilities increased from 0.51 at baseline to 0.68 at 1.5-year follow-up for EQ-5D and from 0.58 to 0.70 for SF-6D. For all severity subgroups, the mean change in EQ-5D and SF-6D utilities was statistically significant. Standardised response means were higher for SF-6D utilities.

Both EQ-5D and SF-6D discriminated between severity subgroups and captured improvements in health over time, but EQ-5D resulted in larger health gains and lower cost-utility ratios, especially for the subgroup with the highest severity of mental illness.

SF-12 Health Survey 1.0 (SF-12 1.0)

Ware JE, Kosinski M, Keller SD. A 12-Item Short Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.

Larson CO. Use of the SF-12 to measure the health of homeless persons. Health Serv Res 2002;37:733–0.

Lamers LM, Bouwmans CAM, van Straten A, et al. Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ 2006;15:1229–36.

Description (with information from an Australian Health Outcomes Collaboration instrument review—http://chsd.uow.edu.au/ahoc): This 12-item self-report measure of generic health status is a shorter version of the SF-36 Health Survey designed to reproduce the Physical Component Summary (PCS) and Mental Component Summary (MCS) scores. It has an administration time of 2 min. There are two questions concerning physical functioning, two questions on role limitations because of physical health problems, one question on bodily pain, one question on general health perceptions, one question on vitality, one question on social functioning, two questions on role limitation because of emotional problems, and two questions on general mental health (psychological distress and psychological well-being).

Extensive general psychometric information is available at http://www.qualitymetric.com/

Information of relevance to our study is from Larson (2002). This study evaluated construct validity of the SF-12 among users of a homeless day shelter. The study compares SF-12 scores from a sample of homeless persons to scores from a sample of the general population.

Reliability

The internal consistency estimates of summary scores were calculated using Cronbach's α. Within the homeless sample these were found to be 0.82 for physical health and 0.79 for mental health. Estimates for the general population were found to be 0.78 for physical health and 0.73 for mental health.

Validity

Construct validity was assessed by the method of extreme groups where multivariate analysis of variance determined if SF-12 summary scores varied for individuals who differed in self-reported clinical symptoms and medical conditions. Four to 10 point differences in physical health (PCS-12) and 5–11 point differences in mental health (MCS-12) were found between those who reported acute symptoms and medical conditions and those who did not. A 13 point difference in PCS-12 scores and a 7–16 point difference in MCS-12 scores were found for those who reported none or few to several symptoms or conditions.

Convergent validity was assessed by correlating SF-12 summary scores with the subscales. Summary scores and subscales yielded satisfactory convergent validity coefficients that ranged from 0.62 to 0.88.

Ware et al (1996) found that SF-12 PCS and MCS scores correlate 0.95 and 0.96 with their SF-36 counterparts.

Quality of Life Index—20 item (QoLI-20)

Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol 1996;31:78–88.

Uttaro T, Lehman A. Graded response modelling of the Quality of Life Interview. Eval Program Plann 1999;22:41–52.

Lançon C, Auquier P, Toumi M, et al. English version of “Evaluation de la qualité de vie des patients schizophrènes: validation de la version courte de la QoLI”. Encephale 2000;26:11–16.

Description (with information from Lehman, 1996):

The original scale was designed to assess the quality of life of people with severe and persistent mental illness. It is a structured self-report interview, conducted by a trained non-clinical interviewer, and elicits participants' ratings of their quality of life. There are 7 subjective scales (living situation, everyday activities, family, social relationships, finances, safety and satisfaction with life in general) and 4 objective scales (everyday activities, enough money, family contacts and contacts with friends). The 20-item version was developed by Uttaro et al (1999) using item-response theory.

Lancon et al (2000)

Scores for nine subjective dimensions were uniformly distributed. The discrimination index ranged from 0.87 to 0.96. Objective items had discrimination indices varying from 0.79 to 0.94.

Item scores were highly correlated with scores on the subscale to which that item contributes (0.6 upwards).

Lehman (1996)

Internal consistency scores (using Cronbach's α) for the original scale range from 0.79 to 0.88 for the subjective scales, and from 0.44 to 0.82 for the objective scales.

Subjective scale α coefficients: living situation (0.83), everyday activities (0.83), family (0.88), social relationships (0.71), finances (0.84), safety (0.84) and satisfaction with life in general (0.74).

Objective scale α coefficients: everyday activities (0.62), enough money (0.78), family contacts (0.69) and contacts with friends (0.72).

Uttaro et al (1999)

20-Item version was derived using item-response theory. Internal consistency was retained.

Recovery Assessment Scale—22 item (RAS-22)

Giffort D, Schmook A, Woody C, et al. Construction of a Scale to Measure Consumer Recovery. Springfield, IL: Illinois Office of Mental Health, 1995.

Corrigan PW, Giffort D, Rashid F, et al. Recovery as a psychological construct. Community Ment Health J 1999;35:231–40.

Corrigan PW, Salzer M, Ralph R, et al. Examining the factor structure of the Recovery Assessment Scale. Schizophr Bull 2004;30:1035–42.

Corrigan et al (2004)

Alphas for factors ranged from 0.74 to 0.87: personal confidence and hope (0.87), willingness to ask for help (0.84), goal and success orientation (0.82), reliance on others (0.74), and no domination by symptoms (0.74).

Reliability

Cronbach's α 0.93 in initial testing.

Respondents in initial testing completed the scale twice within 14 days. Pearson Product Moment Correlation was r=0.88 (n=35).

Validity

RAS total score positively correlated with other measures: Rosenberg Self-Esteem Scale (r=0.55), Empowerment Scale Self-orientation (0.71), Social Support Questionnaire—short version (0.48), Quality of Life Interview—subjective component (0.62), Brief Psychiatric Rating Scale—expanded version (0.44).

Residential Follow-Back Calendar

Tsemberis S, McHugo G, Williams V, et al. Measuring homelessness and residential stability: The Residential Time-Line Follow-Back Inventory. J Commun Psychol 2007;35:29–42.

Test-retest reliability high, with coefficients ranging from 0.80 to 0.91.

Concurrent validity good, assessed by associations between agency and self-reports, with coefficients ranging from 0.84 to 0.92.

Vocational Time-Line Follow-Back (VTLFB)

Latimer EA, Lecomte T, Becker DR, et al. Generalisability of the individual placement and support model of supported employment: results of a Canadian randomised controlled trial. Br J Psychiatry 2006;189:65–73.

The VTLFB was adapted for our study from an instrument developed by Dr Eric Latimer (Montreal site lead investigator) for earlier studies of the outcomes of a vocational intervention—Individual Placement and Supports (IPS) (see reference).

Perceived Housing Quality Items

Tsemberis S, Rogers ES, Rodis E, et al. Housing satisfaction for persons with psychiatric disabilities. J Commun Psychol 2003;31:581–90.

Toro PA, Bellavia CW, Daeschler CV, et al. Evaluating an intervention for homeless persons: results of a field experiment. J Consult Clin Psychol 1997;65:476–84.

For this instrument relevant items were selected from existing questionnaires for which little psychometric information is available. Some items were pre-tested in our study population.

Health, Social and Justice Service Use Inventory (HSJSU)

Ambulatory Health Care Record (AHCR)

Guerriere DN, Ungar WJ, Corey M, et al. Evaluation of the ambulatory and home care record: agreement between self-reports and administrative data. Int J Technol Assess 2006;22:203–10.

Utilisation and Cost Inventory (UAC-I)

Kashner MT, Stensland MD, Lind L, et al. Measuring use and cost of care for patients with mood disorders. Med Care 2009;47:184–90.

Cornell Service Index (CSI)

Sirey J, Beyers BS, Teresi JA, et al. The Cornell Service Index as a measure of health service use. Psychiat Serv 2005;56:1564–69.

Health Service Utilisation Inventory

Browne GB, Arpin K, Corey P, et al. Individual correlates of health service utilisation and the cost of poor adjustment to chronic illness. Med Care 1990;28:43–58.

Utilisation of Hospital and Community Services Form

Forchuk C, Brown SA, Schofield R, et al. Perceptions of health and health service utilisation among homeless and housed psychiatric consumer/survivors. J Psychiatr Ment Health Nurs 2008;15:399–407.

Client Socio-Demographic and Service Receipt Inventory (CSSRI)

Chishom MR, Knapp MRJ, Knudsen HC, et al. Client Socio-Demographic and Service Receipt Inventory—European Version: development of an instrument for international research. Br J Psychiatry 2000;177:s28–33.

Service Use Questionnaire for the Continuity of Mental Health Services (COMHS) Study of Alberta

Adair CE, McDougall GM, Mitton CR, et al. Continuity of care and health outcomes among persons with severe mental illness. Psychiatr Serv 2005;56:1061–9.

The HSJSU was developed specifically for this study because no single health services use questionnaire was identified in the literature that was suitable for our research questions and study population. We used seven existing instruments (as per references) to ensure comprehensive coverage of items and then added items that were relatively unique to our study population (eg, food bank service use). Some of the service use items for which recall was anticipated to be a problem were pre-tested and piloted for the study.

Health Service Access Items (ACC)

Canadian Community Health Survey (CCHS) 2008 Questionnaire. Statistics Canada (http://www.statcan.gc.ca/cgi-bin/imdb/p2SV.pl?Function=getSurvey&SurvId=3226&SurvVer=1&InstaId=15282&InstaVer=5&SDDS=3226&lang=en&db=imdb&adm=8&dis=2)

Khandor E, Mason, K. The Street Health Report 2007. Toronto, ON: Creative Commons, 2007.

Hwang SW, Ueng JJM, Chiu S, et al. Universal health insurance and health care access for homeless persons. Am J Public Health 2010;100:1454–61.

These items were developed by the Toronto site team and are based on the sources in the references.

Community Integration Scale (CIS)

Segal SP, Aviram U. The Mentally Ill in Community Based Sheltered Care: A Study of Community Care and Social Integration. New York: John Wiley & Sons, 1978.

Aubry T, Myner J. Community integration and quality of life: a comparison of persons with psychiatric disabilities in housing programs and community residents who are neighbors. Can J Commun Ment Health 1996;15:5–20.

Chavis DM, Hogge JH, McMillan DW, et al. Sense of community through Brunswick's lens: a first look. J Commun Psychol 1986;14:24–40.

Three sources of items (as referenced) for the concept of community integration were extensively pre-tested in our study population, given that many were not relevant or applicable. Little psychometric information was available for the original scales.

Note that the psychometric values reported here reflect the relevant literature in late 2008/early 2009.

  37 in total

1.  Agency-based tracking of difficult-to-follow populations: runaway and homeless youth programs in St. Louis, Missouri.

Authors:  D E Pollio; S J Thompson; C S North
Journal:  Community Ment Health J       Date:  2000-06

2.  Homelessness and health.

Authors:  S W Hwang
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  Generalisability of the individual placement and support model of supported employment: results of a Canadian randomised controlled trial.

Authors:  Eric A Latimer; Tania Lecomte; Deborah R Becker; Robert E Drake; Isabelle Duclos; Myra Piat; Nicole Lahaie; Marie-Sylvie St-Pierre; Claude Therrien; Haiyi Xie
Journal:  Br J Psychiatry       Date:  2006-07       Impact factor: 9.319

5.  Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults.

Authors:  Michael L Dennis; Ya-Fen Chan; Rodney R Funk
Journal:  Am J Addict       Date:  2006

6.  Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

7.  Evaluating an intervention for homeless persons: results of a field experiment.

Authors:  P A Toro; J M Passero Rabideau; C W Bellavia; C V Daeschler; D D Wall; D M Thomas; S J Smith
Journal:  J Consult Clin Psychol       Date:  1997-06

Review 8.  Tracking and follow-up of marginalized populations: a review.

Authors:  M McKenzie; J P Tulsky; H L Long; M Chesney; A Moss
Journal:  J Health Care Poor Underserved       Date:  1999-11

9.  Recovery as a psychological construct.

Authors:  P W Corrigan; D Giffort; F Rashid; M Leary; I Okeke
Journal:  Community Ment Health J       Date:  1999-06

10.  Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis.

Authors:  Sam Tsemberis; Leyla Gulcur; Maria Nakae
Journal:  Am J Public Health       Date:  2004-04       Impact factor: 9.308

View more
  93 in total

1.  Predictors of Mental Health Recovery in Homeless Adults with Mental Illness.

Authors:  Nick Kerman; John Sylvestre; Tim Aubry; Jino Distasio; Christian G Schütz
Journal:  Community Ment Health J       Date:  2018-12-05

2.  Putting Housing First: The Evidence and Impact.

Authors:  Paula N Goering; David L Streiner
Journal:  Can J Psychiatry       Date:  2015-11       Impact factor: 4.356

3.  Housing Quality in a Randomized Controlled Trial of Housing First for Homeless Individuals with Mental Illness: Correlates and Associations with Outcomes.

Authors:  Carol E Adair; Brianna Kopp; Jino Distasio; Stephen W Hwang; Jennifer Lavoie; Scott Veldhuizen; Jijian Voronka; Andrew F Kaufman; Julian M Somers; Stefanie R LeBlanc; Sonia Cote; Sindi Addorisio; Dominique Matte; Paula Goering
Journal:  J Urban Health       Date:  2016-08       Impact factor: 3.671

4.  A longitudinal study of suicidal ideation among homeless, mentally ill individuals.

Authors:  François Noël; Akm Moniruzzaman; Julian Somers; Jim Frankish; Verena Strehlau; Christian Schütz; Michael Krausz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-10-30       Impact factor: 4.328

Review 5.  Implementing a continuum of evidence-based psychosocial interventions for people with severe mental illness: part 1-review of major initiatives and implementation strategies.

Authors:  Matthew Menear; Catherine Briand
Journal:  Can J Psychiatry       Date:  2014-04       Impact factor: 4.356

6.  Introducing recovery.

Authors:  Rob Whitley
Journal:  Can J Psychiatry       Date:  2014-05       Impact factor: 4.356

7.  Development and initial validation of the Observer-Rated Housing Quality Scale (OHQS) in a multisite trial of housing first.

Authors:  Carol E Adair; Brianna Kopp; Jennifer Lavoie; Jino Distasio; Stephen W Hwang; Aimee Watson; Scott Veldhuizen; Katherine Chislett; Jijian Voronka; Muznah Ahmad; Naveed Ahmed; Paula Goering
Journal:  J Urban Health       Date:  2014-04       Impact factor: 3.671

8.  Costs of services for homeless people with mental illness in 5 Canadian cities: a large prospective follow-up study.

Authors:  Eric A Latimer; Daniel Rabouin; Zhirong Cao; Angela Ly; Guido Powell; Tim Aubry; Jino Distasio; Stephen W Hwang; Julian M Somers; Vicky Stergiopoulos; Scott Veldhuizen; Erica E M Moodie; Alain Lesage; Paula N Goering
Journal:  CMAJ Open       Date:  2017-07-18

9.  Community participation and belonging among formerly homeless adults with mental illness after 12 months of Housing First in Vancouver, British Columbia: a randomized controlled trial.

Authors:  Michelle L Patterson; Akm Moniruzzaman; Julian M Somers
Journal:  Community Ment Health J       Date:  2013-12-10

10.  Daily substance use and mental health symptoms among a cohort of homeless adults in Vancouver, British Columbia.

Authors:  Anita Palepu; Michelle Patterson; Verena Strehlau; Akm Moniruzzamen; Jason Tan de Bibiana; James Frankish; Michael Krausz; Julian Somers
Journal:  J Urban Health       Date:  2013-08       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.